Chun Yi

Investment professional with 12+ years of cross-market experience across China, Australia, and Hong Kong. 30%+ CAGR.

Core strength lies in identifying early-stage growth opportunities before market recognition, with a proven track record across technology, healthcare, consumer, and industrials. Distinctive in deep-tech investing: independently evaluates emerging technologies by reading original research papers and validating underlying models (e.g., machine learning applications) prior to investment. Combines first-principles analysis with real-world demand signals—including proprietary cross-border data and on-the-ground market research—to form early, differentiated investment views.

Experienced in translating these insights into actionable investment decisions and long-term positions.

Tracking Capital Lifecycle to Time Entry & Exit: Once positioned in a high-growth opportunity, I track the full lifecycle of capital evolution—from distressed specialists and industrial capital to global institutional brokers and long-term allocators. I analyze how each layer of capital not only follows but actively shapes the company's fundamentals: industrial capital improves revenue visibility and financing capacity; institutional liquidity enables price discovery; long-term funds signal valuation ceilings.

This framework allows me to identify inflection points, hold through volatility with conviction, and exit before market consensus fully prices the opportunity. It is transferable across industries—consumer, TMT, healthcare, materials, and energies—and has been validated through multiple investment cycles (up to 17.5× returns).

Assistant Professor / Research Economist (Investment & Data Analysis Focus)

– Hunan University, Changsha, China | Aug 2019 – Present

• International presentation: “Pricing Behavior, Collusive Price Floor and Bounded Rationality” 2023–2026, across UAE, Australia, Cyprus, Spain, UK, Hong Kong, Italy, USA. Served as Discussant: 2024–2025 IIOC, USA
• Conducted research on market behavior, pricing strategies, and decision-making under uncertainty, applying quantitative and econometric methods
• Participated in healthcare and pharmaceutical projects across China (2011–2024), developing industry and policy insight relevant to healthcare and biotech investing
• Principal investigator of a provincial project building a regional healthcare data and supervision platform, involving large-scale data integration
• Contributor to NSFC-funded research on crowdfunding and capital allocation under information asymmetry, with implications for investor behavior and market efficiency

Ph.D. Economics, The University of Sydney, 2020

M.Sc. Management Economics, The University of Essex, 2011

B.A. Economics, Huazhong University of Science and Technology, 2007